In contrast, levels of inter-patient heterogeneity, often even within the same breast cancer subtype, were evident for a variety of cells including macrophages, memory B-cells, naïve B-cells, iCAFs, NK cells, NKT cells, CD4 + T-cells, and CD8 + T-cells. This evidence concerns the gene CD4 and breast cancer.